Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Platelet Rich Plasma - Derived Exosomes Therapy for Erectile Dysfunction: A Feasibility Clinical Trial

NCT07124871 is registered in ClinicalTrials.gov with Institute for the Study of Urological Diseases, Greece as lead sponsor.

NCT NCT07124871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07124871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Platelet Rich Plasma - Derived Exosomes Therapy for Erectile Dysfunction: A Feasibility Clinical Trial
Lead sponsor
Institute for the Study of Urological Diseases, Greece
Phase
Phase 2
Overall status
Recruiting
Start date
June 20, 2025
Completion date
May 31, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

erectile dysfunction due to arterial insufficiency